Biosurfactants Show Promise in Bioremediation and Pharmaceuticals

Strategic Insights -

Researchers at the National Institute for Biotechnology and Genetic Engineering (NIBGE) in Faisalabad, Pakistan, have conducted a study on the properties of lipopeptides biosurfactants derived from the AF_3B strain of Bacillus velezensis. The study aimed to investigate the toxicity of these biosurfactants and their potential applications in bioremediation and pharmaceuticals. The researchers discovered that the lipopeptides biosurfactants demonstrated promising surface activity and biocompatibility, with significant inhibition of various bacterial strains and suppression of key mycotoxigenic fungi.

Key Takeaways:

  • The study highlighted the potential of lipopeptides biosurfactants in bioremediation, as they demonstrated the ability to suppress the growth of key mycotoxigenic fungi up to 86%.
  • The researchers found that the lipopeptides biosurfactants produced by Bacillus velezensis strain AF_3B showed significant inhibition of various bacterial strains.
  • In vitro and in ovo toxicity assays revealed that the embryos exhibited normal development and high survival rates after injection with varying doses of lipopeptides biosurfactants, indicating negligible toxicity.
  • The AF_3B strain of Bacillus velezensis was identified as a valuable candidate against bacterial and fungal diseases and foodborne pathogens.
  • The study underscores the potential of lipopeptides biosurfactants in diverse industrial applications, including bioremediation and pharmaceuticals.

Statistics:

  • Up to 86% suppression of key mycotoxigenic fungi (Aspergillus niger and Fusarium oxysporum) by lipopeptides biosurfactants.
  • The embryos exhibited normal development and high survival rates (up to 100%) after injection with varying doses of lipopeptides biosurfactants.
  • The tocicity results of lipopeptides biosurfactants at 30mg/mL, 15mg/mL, 7.5mg/mL, 3.75mg/mL and 1.87mg/mL injected to the chicken embryos.

Sources:

  • "In Vitro and In Ovo Toxicity Analysis of Lipopeptides Biosurfactants Produced by Bacillus velezensis Strain AF_3B." Veterinary Medicine and Science, 2025;11(5).
  • NewsRx LLC (2025, August 18). "New Veterinary Medicine Findings from National Institute for Biotechnology and Genetic Engineering (NIBGE) Discussed (In Vitro and In Ovo Toxicity Analysis of Lipopeptides Biosurfactants Produced by Bacillus velezensis Strain AF_3B)." Veterinary Week.